The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients

Ai Peng250 enrolled

Overview

The purpose of this study is to evaluate whether tyrosine kinase receptor Axl affects the dialysis prognosis in chronic hemodialysis patients

It is reported that hemodialysis (HD) patients often develop chronic systemic inflammatoion, and increased inflammatory activity is associated with vascular access failure, cardiovascular disease and death in HD patients. The interaction of Axl and its ligand Gas6 plays an important role in modulating immune response, inhabiting toll-like receptor (TLR) signaling and suppressing inflammatory cytokines production. Thus, we want to investigate the relationship between tyrosine kinase receptor Axl and the dialysis prognosis in HD patients in three-years follow-up.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Hemodialysis Complication

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * hemodialysis for more than 6 months Exclusion Criteria: * patients who received warfarin therapy; * patients with chronic infectious disease or acute infection; * patients with hemodialysis inadequacy; * the age of patients is older than 65 years or younger than 18 years. * patients who can not sign an informed consent or disagree to follow up

Locations (1)

Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, China

Outcomes

Primary Outcomes

death

Time frame: 3 years

dialysis complication

vascular access failure, stroke, acute coronary syndrome, heart failure

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.